Skip to main content
CHYM
NASDAQ Finance

Chime 10-Q Details Q3 Profit, 9% Workforce Cut and New $500M Warehouse Facility

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Software Stocks · Technology
Sentiment info
Positive
Importance info
7
Price
$30.18
Mkt Cap
$11.426B
52W Low
$15.88
52W High
$35.55
52W Position info
90% above low
Off High info
15% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

CHYM sits 90% above its 52-week low of $15.88.

Summary

Chime's Q3 10-Q confirms $718M revenue (+32%), $43.7M net income and $137.3M adjusted EBITDA, and discloses a 9% workforce cut, a new $500M warehouse facility and new 10b5-1 selling plans from the CEO and other executives.


Key Events · Earnings and Guidance · CHYM

  • Q3 Profit Confirmed at $43.7M

    Revenue of $718.0M rose 32% year over year and net income was $43.7M, or $0.11 diluted EPS, versus a $54.7M loss a year ago.

  • Adjusted EBITDA Jumps to $137.3M

    Adjusted EBITDA margin reached 19% versus 5% a year ago, and transaction margin improved to 74% from 69%.

  • 9% Workforce Cut Costs $17.1M

    The July 31, 2026 restructuring eliminated about 9% of staff for $17.1M in net cash charges, of which $8.1M was paid by September 30.

  • New $500M Warehouse Facility Drawn $100M

    A June 2026 facility with Goldman Sachs carries a $200M commitment plus $300M uncommitted, and $100.0M was outstanding at quarter end to fund MyPay loans.


Analysis · CHYM · Finance

The 10-Q confirms the Q3 beat first reported in the 2026-11-04 8-K and fills in the numbers behind it: $43.7M of net income, $0.11 diluted EPS and $137.3M of adjusted EBITDA (19% margin) versus $28.8M a year ago. Revenue growth is broadening — platform-related revenue rose 52% to $273.6M on MyPay, Instant Loans and instant transfers, while Active Members grew 20% to 10.9M. Two items deserve attention: the July 31 restructuring cut about 9% of staff for $17.1M in charges, and Chime drew $100M on a new $500M Goldman Sachs warehouse facility to fund MyPay loans. The filing also discloses new 10b5-1 selling plans adopted in September by the CEO (up to 1.75M shares), the President/Interim CFO (750,000) and Co-Founder King (2.25M), which adds to the heavy insider distribution already visible this year.

How filings like this one have moved

In the 30 days to Nov 6, 2026, 35.2% of the 2653 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CHYM was trading at $30.18 on NASDAQ in the Finance sector, with a market capitalization of approximately $11.4B. The 52-week trading range was $15.88 to $35.55. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CHYM - Latest Insights

CHYM
Nov 04, 2026, 4:09 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $31.62
Real-time Price: $29.99 info
Change: -$1.63 (-5%) info
Market Cap: $11.426B info
CHYM
Nov 04, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
9
Price at Filing: $30.61
Real-time Price: $29.99 info
Change: -$0.620 (-2%) info
Market Cap: $11.426B info
CHYM
Sep 16, 2026, 8:21 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $31.38
Real-time Price: $29.99 info
Change: -$1.39 (-4%) info
Market Cap: $11.426B info
CHYM
Sep 09, 2026, 9:13 AM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $34.30
Real-time Price: $29.99 info
Change: -$4.31 (-13%) info
Market Cap: $11.426B info
CHYM
Sep 09, 2026, 5:15 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $35.80
Real-time Price: $29.99 info
Change: -$5.81 (-16%) info
Market Cap: $11.426B info